Rafferty Asset Management, LLC Travere Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 91,771 shares of TVTX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,771

Previous 182,292 49.66%

Holding current value

$1.57 Million

Previous $1.5 Million 14.35%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.89 - $15.21 $714,210 - $1.38 Million	-90,521 Reduced 49.66%	91,771 $1.28 Million
Q2 2024 Aug 13, 2024	SELL	$5.26 - $8.28 $2.17 Million - $3.42 Million	-412,940 Reduced 69.37%	182,292 $1.5 Million
Q1 2024 May 13, 2024	BUY	$7.18 - $9.82 $1.19 Million - $1.63 Million	166,071 Added 38.7%	595,232 $4.59 Million
Q4 2023 Feb 13, 2024	BUY	$5.44 - $9.5 $365,393 - $638,096	67,168 Added 18.56%	429,161 $3.86 Million
Q3 2023 Nov 13, 2023	SELL	$7.64 - $17.25 $1.04 Million - $2.35 Million	-136,259 Reduced 27.35%	361,993 $3.24 Million
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $2.63 Million - $3.88 Million	171,782 Added 52.62%	498,252 $7.65 Million
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $125,025 - $160,596	7,016 Added 2.2%	326,470 $7.34 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $2.1 Million - $2.97 Million	113,687 Added 55.25%	319,454 $6.72 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $1.66 Million - $2.08 Million	72,542 Added 54.45%	205,767 $5.07 Million
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $586,696 - $840,820	-28,018 Reduced 17.38%	133,225 $3.23 Million
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $284,335 - $368,515	-12,043 Reduced 6.95%	161,243 $4.16 Million
Q4 2021 Feb 10, 2022	BUY	$24.34 - $31.17 $1.79 Million - $2.29 Million	73,364 Added 73.42%	173,286 $5.38 Million
Q3 2021 Nov 10, 2021	SELL	$12.98 - $25.03 $450,912 - $869,517	-34,739 Reduced 25.8%	99,922 $2.42 Million
Q2 2021 Aug 10, 2021	BUY	$14.11 - $26.4 $519,008 - $971,071	36,783 Added 37.58%	134,661 $1.97 Million
Q1 2021 May 10, 2021	BUY	$23.37 - $31.77 $2.03 Million - $2.76 Million	86,909 Added 792.31%	97,878 $2.44 Million
Q4 2020 Feb 10, 2021	BUY	$19.17 - $27.87 $210,275 - $305,706	10,969 New	10,969 $299,000

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.1B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Travere Therapeutics, Inc. Transaction History